Drug repurposing trends shorten timelines
This white paper explores the drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.
Learn about:
- The drug repurposing development pathway
- The promise of repurposed drug
- CDMO support and critical role as partners
Biocytogen Co Ltd
Draupnir Bio ApS